Gene expression profile of metastatic colon cancer cells resistant to cisplatin-induced apoptosis.
Huerta S, Harris DM, Jazirehi A, Bonavida B, Elashoff D, Livingston EH, Heber D. Int J Oncol. March 2003 22(3) 663-70.
PC-SPES inhibits colon cancer growth in vitro and in vivo.
Huerta S, Arteaga JR, Irwin RW, Ikezoe T, Heber D, Koeffler HP. Cancer Res. September 2002 62(18) 5204-9.
1alpha,25-(OH)(2)-D(3) and its synthetic analogue decrease tumor load in the Apc(min) Mouse.
Huerta S, Irwin RW, Heber D, Go VL, Koeffler HP, Uskokovic MR, Harris DM. Cancer Res. February 2002 62(3) 741-6.
Alternative mRNA splicing in colon cancer causes loss of expression of neural cell adhesion molecule.
Huerta S, Srivatsan ES, Venkatesan N, Peters J, Moatamed F, Renner S, Livingston EH. Surgery November 2001 130(5) 834-43.
A strategy for reducing surgical backlogs: lessons from a veterans administration hospital.
Murray BW, Huerta S, Anthony T Am Surg 2011 May 77 5 597-601
Radiosensitizing agents for the management of rectal cancer.
Huerta S Anticancer Drugs 2011 Apr 22 4 305-7
Oxaliplatin as a radiosensitizing agent in rectal cancer.
Huerta S, Hrom J Anticancer Drugs 2011 Apr 22 4 317-23
Murine orthotopic model for the assessment of chemoradiotherapeutic interventions in rectal cancer.
Huerta S, Gao X, Saha D Anticancer Drugs 2011 Apr 22 4 371-6
Evaluating an evidence-based bundle for preventing surgical site infection: a randomized trial.
Anthony T, Murray BW, Sum-Ping JT, Lenkovsky F, Vornik VD, Parker BJ, McFarlin JE, Hartless K, Huerta S Arch Surg 2011 Mar 146 3 263-9
Surgical site infection in colorectal surgery: a review of the nonpharmacologic tools of prevention.
Murray BW, Huerta S, Dineen S, Anthony T J. Am. Coll. Surg. 2010 Dec 211 6 812-22